Cargando…

Role of the AMPK/SIRT1 pathway in non-alcoholic fatty liver disease (Review)

Non-alcoholic fatty liver disease (NAFLD) is an increasingly prevalent ailment worldwide. Moreover, de novo lipogenesis (DNL) is considered a critical factor in the development of NAFLD; hence, its inhibition is a promising target for the prevention of fatty liver disease. There is evidence to indic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anggreini, Putri, Kuncoro, Hadi, Sumiwi, Sri Adi, Levita, Jutti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827347/ https://www.ncbi.nlm.nih.gov/pubmed/36562343 http://dx.doi.org/10.3892/mmr.2022.12922

Ejemplares similares

Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients
por: Susilawati, Elis, et al.
Publicado: (2023)

Pharmacology activity, toxicity, and clinical trials of Erythrina genus plants (Fabaceae): an evidence-based review
por: Susilawati, Elis, et al.
Publicado: (2023)

Chitin Extracted from the Shell of Blue Swimming Crabs (Portunus pelagicus Linn.) Inhibits NF-kappaB p65 in Ethanol-Induced Gastric Ulcerative Wistar Rats
por: Amelia, Renny, et al.
Publicado: (2023)

Effect of the roselle (Hibiscus sabdariffa L.) calyces drink on the physiological parameters of healthy adult subjects
por: Diantini, Ajeng, et al.
Publicado: (2021)

Silibinin Restores NAD(+) Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
por: Salomone, Federico, et al.
Publicado: (2017)

Therapeutic effects of isosteviol sodium on non-alcoholic fatty liver disease by regulating autophagy via Sirt1/AMPK pathway
por: Mei, Ying, et al.
Publicado: (2022)

11β-HSD1 Inhibitor Alleviates Non-Alcoholic Fatty Liver Disease by Activating the AMPK/SIRT1 Signaling Pathway
por: Chen, Ying, et al.
Publicado: (2022)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
por: Long, Jun-Ke, et al.
Publicado: (2019)

SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease
por: Cho, Eun-Hee
Publicado: (2014)

The AMPK pathway in fatty liver disease
por: Fang, Chunqiu, et al.
Publicado: (2022)

Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways
por: Zhou, Fei, et al.
Publicado: (2022)

Tricin-enriched Zizania latifolia ameliorates non-alcoholic fatty liver disease through AMPK-dependent pathways
por: Chang, Bo Yoon, et al.
Publicado: (2023)

Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet
por: Liou, Chian-Jiun, et al.
Publicado: (2019)

Astaxanthin improves fatty acid dysregulation in diabetes by controlling the AMPK-SIRT1 pathway
por: Taghiyar, Sana, et al.
Publicado: (2023)

The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease
por: Werge, Mikkel Parsberg, et al.
Publicado: (2021)

Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway
por: Zhang, Ying, et al.
Publicado: (2020)

Correlation between Hepatocyte Growth Factor (HGF) with D-Dimer and Interleukin-6 as Prognostic Markers of Coagulation and Inflammation in Long COVID-19 Survivors
por: Zaira, Bena, et al.
Publicado: (2023)

The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
por: Xu, Hao, et al.
Publicado: (2021)

Geniposide alleviates non‐alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways
por: Shen, Bingyu, et al.
Publicado: (2020)

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway
por: Li, Qian, et al.
Publicado: (2022)

Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway
por: Zhang, Ning, et al.
Publicado: (2023)

Le Carbone prevents liver damage in non-alcoholic steatohepatitis-hepatocellular carcinoma mouse model via AMPKα-SIRT1 signaling pathway activation
por: Afrin, Mst. Rejina, et al.
Publicado: (2021)

Efficacy, Safety, and Drug–Drug Interactions for Insomnia Therapy in COVID-19 Patients
por: Saputra, Billy Dwi, et al.
Publicado: (2022)

Efficacy and Safety of Add-On Plant-Based Drugs for COVID-19 Patients: A Review of the Randomized Control Trials
por: Diantini, Ajeng, et al.
Publicado: (2023)

Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome
por: Tian, Ruifeng, et al.
Publicado: (2023)

Emerging roles of SIRT1 in fatty liver diseases
por: Ding, Ren-Bo, et al.
Publicado: (2017)

The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
por: JASIRWAN, Chyntia Olivia Maurine, et al.
Publicado: (2019)

Molecular pathways in non-alcoholic fatty liver disease
por: Berlanga, Alba, et al.
Publicado: (2014)

Emerging Roles of SIRT1 in Alcoholic Liver Disease
por: Ren, Ruixue, et al.
Publicado: (2020)

The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway
por: Zhu, Juanjuan, et al.
Publicado: (2016)

Omega-3 Polyunsaturated Fatty Acids Antagonize Macrophage Inflammation via Activation of AMPK/SIRT1 Pathway
por: Xue, Bingzhong, et al.
Publicado: (2012)

Pharmacological and Clinical Studies of Medicinal Plants That Inhibit Dipeptidyl Peptidase-IV
por: Rohani, et al.
Publicado: (2023)

A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies
por: von Loeffelholz, Christian, et al.
Publicado: (2021)

Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK
por: Yang, Ying, et al.
Publicado: (2021)

Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK
por: ALTamimi, Jozaa Z., et al.
Publicado: (2021)

Folic acid supplementation prevents high fructose-induced non-alcoholic fatty liver disease by activating the AMPK and LKB1 signaling pathways
por: Kim, Hyewon, et al.
Publicado: (2020)

Radix Polygoni Multiflori and Its Main Component Emodin Attenuate Non-Alcoholic Fatty Liver Disease in Zebrafish by Regulation of AMPK Signaling Pathway
por: Yu, Linyuan, et al.
Publicado: (2020)

Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways
por: Li, Chun-Xiao, et al.
Publicado: (2019)

Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis
por: ElBaset, Marwan A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_147eupsdbd6hfbkrjtp748tkfg